Neoantigen Cancer Vaccine Market, By Product, By Type, By Route of Administration, By Delivery Mechanism, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

Description

REPORT HIGHLIGHT

The Neoantigen Cancer Vaccine Market size was valued at USD 46,059.43 million in 2023, expanding at a CAGR of 73.40% from 2024 to 2032.

Neoantigen cancer vaccines constitute a form of personalized immunotherapy aimed at activating the immune system to identify and combat cancerous cells. These vaccines focus on neoantigens, which are unique antigens generated from mutations within tumor cells. The development of neoantigen cancer vaccines marks a notable progression in the field of cancer immunotherapy, utilizing the distinct features of an individual's tumor to bolster the body's inherent capacity to combat cancer.

Neoantigen Cancer Vaccine Market- Market Dynamics

The growing adoption of personalized medicine aimed at customizing patient treatment is anticipated to propel market expansion. This approach emphasizes the development of treatment plans that are specifically designed to align with individual patient characteristics, such as genetic profiles, tumor features, and overall health status. Central to this methodology are Neoantigen vaccines, which are meticulously crafted based on the distinct mutations found in a patient's tumor. Notably, the number of personalized medicines available in the market increased from 132 to 286, with these therapies representing 25% of the new drugs approved by the FDA in 2019.

Moreover, enhanced funding from both public and private sectors, including contributions from pharmaceutical companies and venture capitalists, is driving research and development efforts in this domain. Nevertheless, the complexity of manufacturing processes may pose challenges to market growth.

Neoantigen Cancer Vaccine Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 73.40% over the forecast period (2024-2032)

Based on Product segmentation, Personalized was predicted to show maximum market share in the year 2023

Based on Type segmentation, Nucleic Acid was the leading type in 2023

Based on Application segmentation, Lung Cancer was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Neoantigen Cancer Vaccine Market- Segmentation Analysis:

The Global Neoantigen Cancer Vaccine Market is segmented based on Product, Type, Route of Administration, Delivery Mechanism, Application, and Region.

The market is classified into two segments according to product: Personalized and Off-the-shelf. The Personalized segment holds a dominant position in the market. Personalized neoantigen vaccines are frequently used in conjunction with checkpoint inhibitors, such as PD-1 or CTLA-4 inhibitors, to enhance the immune response. This combinatorial strategy is under investigation to address the shortcomings of existing immunotherapies and to enhance patient outcomes.

The market is segmented into four categories according to type: Dendritic Cell, Nucleic Acid, Synthetic Long Peptide, and Tumor Cell. The Nucleic Acid category holds a leading position in the market. The Neoantigen Cancer Vaccine Market is significantly linked to progress in nucleic acid technologies, especially in the creation of novel vaccines aimed at addressing tumor-specific mutations.

The market is segmented into three categories according to the Route of Administration: Intramuscular, Intravenous, and Transdermal. The Neoantigen Cancer Vaccine Market is experiencing significant growth, with different routes of administration being essential for the advancement and distribution of these tailored therapies.

The market is categorized into four segments according to the Delivery Mechanism: Liposomes, Virosomes, Gene gun, Electroporation, and Others. These mechanisms are essential for effectively delivering personalized vaccines to the targeted cells, thereby facilitating a robust immune response to the cancer-specific neoantigens.

The market is segmented into four categories according to application: Brain Cancer, Gastrointestinal Cancer, Lung Cancer, Melanoma, and Others. Lung Cancer holds a leading position in the market. In the case of lung cancer, the elevated mutation burden offers a diverse range of potential neoantigens for targeting, thereby positioning personalized vaccines as a highly promising approach.

Neoantigen Cancer Vaccine Market- Geographical Insights

North America features a robust clinical trial framework, with a multitude of research institutions and hospitals engaged in the development of Neoantigen vaccines. The regulatory landscape in this region facilitates streamlined trial processes, promoting the advancement and evaluation of innovative therapies. Cancer has impacted nearly every individual in the United States, and there is significant public support for increased funding in cancer research. A recent survey conducted by ASCO, involving over 4,000 Americans, revealed that approximately 73% believe the government should allocate more resources to discovering treatments and cures for cancer, even if this necessitates higher taxes or an increase in the national deficit. Europe represents the second largest region for market expansion, driven by advancements in genomic technologies. Overall, the global environment for Neoantigen cancer vaccines is vibrant, presenting numerous growth opportunities across different regions.

Neoantigen Cancer Vaccine Market- Competitive Landscape:

The Neoantigen cancer vaccine market exhibits a highly competitive environment, with major players actively utilizing cutting-edge technologies, establishing strategic alliances, and making significant investments in research and development. These companies are collaborating with research institutions, healthcare facilities, and other biotechnology firms to strengthen their R&D efforts and accelerate the creation of neoantigen vaccines. The competitive landscape is expected to change swiftly, driven by continuous technological advancements and a commitment to enhancing patient outcomes.

Recent Developments:

On September 10, 2024, OSE Immunotherapeutics SA announced the commencement of its international Phase 3 clinical trial, named 'Artemia,' for Tedopi, a therapeutic cancer vaccine based on neoepitopes intended for off-the-shelf application. This trial is aimed at providing second-line treatment for patients diagnosed with metastatic non-small cell lung cancer (NSCLC). The study has received review and approval from health authorities across 14 countries, including the US FDA, Canada, Europe, and the United Kingdom, marking a significant advancement in the registration process for Tedopi, in conjunction with the development of a companion diagnostic for HLA-A2 positive patients.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NEOANTIGEN CANCER VACCINE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

OSE Immunotherapeutics SA
Gritstone Bio Inc.
BioNTech SE
Hoffmann-La Roche Ltd.
Pfizer Inc.
Merck & Co. Inc.
Moderna Inc.
Avidea Technologies Inc.
Eli Lilly and Company
Vaccibody AS
Agenus Inc.
Novogene Co. Ltd.
ZIOPHARM Oncology Inc.
ISA Pharmaceuticals B.V.
BrightPath Biotherapeutics Co. Ltd.
Vaximm AG
Medigene AG
Genocea Biosciences Inc.
Advaxis Inc.
Nouscom AG
Others

GLOBAL NEOANTIGEN CANCER VACCINE MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

Personalized
Off-the-shelf

GLOBAL NEOANTIGEN CANCER VACCINE MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

Dendritic Cell
Nucleic Acid
Synthetic Long Peptide
Tumor Cell

GLOBAL NEOANTIGEN CANCER VACCINE MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2019 - 2032

Intramuscular
Intravenous
Transdermal

GLOBAL NEOANTIGEN CANCER VACCINE MARKET, BY DELIVERY MECHANISM- MARKET ANALYSIS, 2019 - 2032

Liposomes
Virosomes
Gene gun
Electroporation
Others

GLOBAL NEOANTIGEN CANCER VACCINE MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

Brain Cancer
Gastrointestinal Cancer
Lung Cancer
Melanoma
Others

GLOBAL NEOANTIGEN CANCER VACCINE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

Product Code: ANV4229

1. Neoantigen Cancer Vaccine Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Neoantigen Cancer Vaccine Market Snippet by Product
- 2.1.2. Neoantigen Cancer Vaccine Market Snippet by Type
- 2.1.3. Neoantigen Cancer Vaccine Market Snippet by Route of Administration
- 2.1.4. Neoantigen Cancer Vaccine Market Snippet by Delivery Mechanism
- 2.1.5. Neoantigen Cancer Vaccine Market Snippet by Application
- 2.1.6. Neoantigen Cancer Vaccine Market Snippet by Country
- 2.1.7. Neoantigen Cancer Vaccine Market Snippet by Region
2.2. Competitive Insights

3. Neoantigen Cancer Vaccine Key Market Trends

3.1. Neoantigen Cancer Vaccine Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Neoantigen Cancer Vaccine Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Neoantigen Cancer Vaccine Market Opportunities
3.4. Neoantigen Cancer Vaccine Market Future Trends

4. Neoantigen Cancer Vaccine Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Neoantigen Cancer Vaccine Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Neoantigen Cancer Vaccine Market Landscape

6.1. Neoantigen Cancer Vaccine Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Neoantigen Cancer Vaccine Market - By Product

7.1. Overview
- 7.1.1. Segment Share Analysis, By Product, 2023 & 2032 (%)
- 7.1.2. Personalized
- 7.1.3. Off-the-shelf

8. Neoantigen Cancer Vaccine Market - By Type

8.1. Overview
- 8.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
- 8.1.2. Dendritic Cell
- 8.1.3. Nucleic Acid
- 8.1.4. Synthetic Long Peptide
- 8.1.5. Tumor Cell

9. Neoantigen Cancer Vaccine Market - By Route of Administration

9.1. Overview
- 9.1.1. Segment Share Analysis, By Route of Administration, 2023 & 2032 (%)
- 9.1.2. Intramuscular
- 9.1.3. Intravenous
- 9.1.4. Transdermal

10. Neoantigen Cancer Vaccine Market - By Delivery Mechanism

10.1. Overview
- 10.1.1. Segment Share Analysis, By Delivery Mechanism, 2023 & 2032 (%)
- 10.1.2. Liposomes
- 10.1.3. Virosomes
- 10.1.4. Gene gun
- 10.1.5. Electroporation
- 10.1.6. Others

11. Neoantigen Cancer Vaccine Market - By Application

11.1. Overview
- 11.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
- 11.1.2. Brain Cancer
- 11.1.3. Gastrointestinal Cancer
- 11.1.4. Lung Cancer
- 11.1.5. Melanoma
- 11.1.6. Others

12. Neoantigen Cancer Vaccine Market- By Geography

12.1. Introduction
- 12.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
12.2. North America
- 12.2.1. Overview
- 12.2.2. Neoantigen Cancer Vaccine Key Manufacturers in North America
- 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 12.2.5. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.2.6. North America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 12.2.7. North America Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
- 12.2.8. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.2.9. U.S.
  - 12.2.9.1. Overview
  - 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.2.9.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.2.9.4. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.2.9.5. U.S. Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.2.9.6. U.S. Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
  - 12.2.9.7. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.2.10. Canada
  - 12.2.10.1. Overview
  - 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.2.10.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.2.10.4. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.2.10.5. Canada Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.2.10.6. Canada Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
  - 12.2.10.7. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3. Europe
- 12.3.1. Overview
- 12.3.2. Neoantigen Cancer Vaccine Key Manufacturers in Europe
- 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 12.3.5. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.3.6. Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 12.3.7. Europe Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
- 12.3.8. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.3.9. Germany
  - 12.3.9.1. Overview
  - 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.9.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.3.9.4. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.3.9.5. Germany Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.3.9.6. Germany Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
  - 12.3.9.7. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.3.10. Italy
  - 12.3.10.1. Overview
  - 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.10.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.3.10.4. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.3.10.5. Italy Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.3.10.6. Italy Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
  - 12.3.10.7. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.3.11. United Kingdom
  - 12.3.11.1. Overview
  - 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.11.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.3.11.4. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.3.11.5. United Kingdom Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.3.11.6. United Kingdom Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
  - 12.3.11.7. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.3.12. France
  - 12.3.12.1. Overview
  - 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.12.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.3.12.4. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.3.12.5. France Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.3.12.6. France Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
  - 12.3.12.7. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.3.13. Russia
  - 12.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.13.2. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.3.13.3. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.3.13.4. Russia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.3.13.5. Russia Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
  - 12.3.13.6. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.3.14. Netherlands
  - 12.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.14.2. Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.3.14.3. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.3.14.4. Netherlands Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.3.14.5. Netherlands Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
  - 12.3.14.6. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.3.15. Sweden
  - 12.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.15.2. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.3.15.3. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.3.15.4. Sweden Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.3.15.5. Sweden Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
  - 12.3.15.6. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.3.16. Poland
  - 12.3.16.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.16.2. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.3.16.3. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.3.16.4. Poland Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.3.16.5. Poland Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
  - 12.3.16.6. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.3.17. Rest of Europe
  - 12.3.17.1. Overview
  - 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.3.17.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.3.17.4. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.3.17.5. Rest of the Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.3.17.6. Rest of the Europe Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
  - 12.3.17.7. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4. Asia Pacific (APAC)
- 12.4.1. Overview
- 12.4.2. Neoantigen Cancer Vaccine Key Manufacturers in Asia Pacific
- 12.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.4.4. Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 12.4.5. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.4.6. Asia Pacific Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 12.4.7. Asia Pacific Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
- 12.4.8. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.4.9. India
  - 12.4.9.1. Overview
  - 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.9.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.4.9.4. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.4.9.5. India Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.4.9.6. India Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
  - 12.4.9.7. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.4.10. China
  - 12.4.10.1. Overview
  - 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.10.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.4.10.4. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.4.10.5. China Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.4.10.6. China Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
  - 12.4.10.7. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.4.11. Japan
  - 12.4.11.1. Overview
  - 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.11.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.4.11.4. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.4.11.5. Japan Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.4.11.6. Japan Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
  - 12.4.11.7. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.4.12. South Korea
  - 12.4.12.1. Overview
  - 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.12.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.4.12.4. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.4.12.5. South Korea Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.4.12.6. South Korea Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
  - 12.4.12.7. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.4.13. Australia
  - 12.4.13.1. Overview
  - 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.13.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.4.13.4. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.4.13.5. Australia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.4.13.6. Australia Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
  - 12.4.13.7. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.4.14. Thailand
  - 12.4.14.1. Overview
  - 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.14.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.4.14.4. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.4.14.5. Thailand Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.4.14.6. Thailand Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
  - 12.4.14.7. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.4.15. Indonesia
  - 12.4.15.1. Overview
  - 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.15.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.4.15.4. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.4.15.5. Indonesia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.4.15.6. Indonesia Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
  - 12.4.15.7. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.4.16. Philippines
  - 12.4.16.1. Overview
  - 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.16.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.4.16.4. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.4.16.5. Philippines Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.4.16.6. Philippines Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
  - 12.4.16.7. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.4.17. Rest of APAC
  - 12.4.17.1. Overview
  - 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.4.17.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.4.17.4. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.4.17.5. Rest of APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.4.17.6. Rest of APAC Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
  - 12.4.17.7. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5. Latin America
- 12.5.1. Overview
- 12.5.2. Neoantigen Cancer Vaccine Key Manufacturers in Latin America
- 12.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.5.4. Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 12.5.5. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.5.6. Latin America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 12.5.7. Latin America Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
- 12.5.8. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.5.9. Brazil
  - 12.5.9.1. Overview
  - 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.9.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.5.9.4. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.5.9.5. Brazil Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.5.9.6. Brazil Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
  - 12.5.9.7. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.5.10. Mexico
  - 12.5.10.1. Overview
  - 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.10.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.5.10.4. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.5.10.5. Mexico Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.5.10.6. Mexico Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
  - 12.5.10.7. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.5.11. Argentina
  - 12.5.11.1. Overview
  - 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.11.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.5.11.4. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.5.11.5. Argentina Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.5.11.6. Argentina Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
  - 12.5.11.7. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.5.12. Colombia
  - 12.5.12.1. Overview
  - 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.12.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.5.12.4. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.5.12.5. Colombia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.5.12.6. Colombia Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
  - 12.5.12.7. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.5.13. Rest of LATAM
  - 12.5.13.1. Overview
  - 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.5.13.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.5.13.4. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.5.13.5. Rest of LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.5.13.6. Rest of LATAM Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
  - 12.5.13.7. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6. Middle East and Africa
- 12.6.1. Overview
- 12.6.2. Neoantigen Cancer Vaccine Key Manufacturers in Middle East and Africa
- 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.6.4. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 12.6.5. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.6.6. Middle East and Africa Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 12.6.7. Middle East and Africa Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
- 12.6.8. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.6.9. Saudi Arabia
  - 12.6.9.1. Overview
  - 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.9.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.6.9.4. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.6.9.5. Saudi Arabia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.6.9.6. Saudi Arabia Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
  - 12.6.9.7. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.6.10. United Arab Emirates
  - 12.6.10.1. Overview
  - 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.10.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.6.10.4. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.6.10.5. United Arab Emirates Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.6.10.6. United Arab Emirates Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
  - 12.6.10.7. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.6.11. Israel
  - 12.6.11.1. Overview
  - 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.11.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.6.11.4. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.6.11.5. Israel Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.6.11.6. Israel Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
  - 12.6.11.7. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.6.12. Turkey
  - 12.6.12.1. Overview
  - 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.12.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.6.12.4. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.6.12.5. Turkey Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.6.12.6. Turkey Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
  - 12.6.12.7. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.6.13. Algeria
  - 12.6.13.1. Overview
  - 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.13.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.6.13.4. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.6.13.5. Algeria Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.6.13.6. Algeria Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
  - 12.6.13.7. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.6.14. Egypt
  - 12.6.14.1. Overview
  - 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.14.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.6.14.4. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.6.14.5. Egypt Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.6.14.6. Egypt Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
  - 12.6.14.7. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 12.6.15. Rest of MEA
  - 12.6.15.1. Overview
  - 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 12.6.15.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 12.6.15.4. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 12.6.15.5. Rest of MEA Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 12.6.15.6. Rest of MEA Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
  - 12.6.15.7. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- Neoantigen Cancer Vaccine Industry

13.1. Competitive Dashboard
13.2. Company Profiles
- 13.2.1. OSE Immunotherapeutics SA
- 13.2.2. Gritstone bio Inc.
- 13.2.3. BioNTech SE
- 13.2.4. Hoffmann-La Roche Ltd.
- 13.2.5. Pfizer Inc.
- 13.2.6. Merck & Co. Inc.
- 13.2.7. Moderna Inc.
- 13.2.8. Avidea Technologies Inc.
- 13.2.9. Eli Lilly and Company
- 13.2.10. Vaccibody AS
- 13.2.11. Agenus Inc.
- 13.2.12. Novogene Co. Ltd.
- 13.2.13. ZIOPHARM Oncology Inc.
- 13.2.14. ISA Pharmaceuticals B.V.
- 13.2.15. BrightPath Biotherapeutics Co. Ltd.
- 13.2.16. Vaximm AG
- 13.2.17. Medigene AG
- 13.2.18. Genocea Biosciences Inc.
- 13.2.19. Advaxis Inc.
- 13.2.20. Nouscom AG
- 13.2.21. Others

14. 360 Degree Analyst View

15. Appendix

15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us